HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CTEV

Claritev Corporation (NYSE)

Healthcare — Health Information Services

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.

Buy 1.7 / 5 6 analysts
$24.96
$-3.73 (-12.98%)
Target: $36.83 (47.6%)
Sign in to add CTEV to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$552.35M
P/E Ratio (TTM)-
Forward P/E4.74
EPS (TTM)$-17.33
Dividend Yield-
Profit Margin-29.27%
Revenue Growth5.80%
ROE-
Debt/Equity-
Recommendation Buy 1.7
Analyst Target$36.83
Analysts6
Indexes NYSE

Technical Indicators

RSI (14)58.1
Beta0.77
SMA 20-
SMA 40-
52-Week High$74.07
52-Week Low$11.50
50-Day Avg$26.28
200-Day Avg$34.08
Avg Volume150.5K
Volume117.6K

Performance Analysis

NEUTRAL

CTEV presents a mixed picture with both positive and negative indicators.

~ Trading at 22% of its 52-week range.
+ RSI at 58.1 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 5.8% year-over-year.
- Operating at a loss with -29.3% margin.
+ Wall Street consensus is "Buy" from 6 analysts.
+ Average analyst target of $36.83 implies 47.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:04 UTC

Back to Screener Export Report